Keywords
Last Name
Institution

CAROL J BAKER

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 Bates, Suite 1120
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baker CJ. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations. J Adolesc Health. 2016 Aug; 59(2 Suppl):S29-37. PMID: 27449147.
      View in: PubMed
    2. Campisi E, Rinaudo CD, Donati C, Barucco M, Torricelli G, Edwards MS, Baker CJ, Margarit I, Rosini R. Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages. Sci Rep. 2016; 6:29799. PMID: 27411639; PMCID: PMC4944191.
    3. Bowen MD, Mijatovic-Rustempasic S, Esona MD, Teel EN, Gautam R, Sturgeon M, Azimi PH, Baker CJ, Bernstein DI, Boom JA, Chappell J, Donauer S, Edwards KM, Englund JA, Halasa NB, Harrison CJ, Johnston SH, Klein EJ, McNeal MM, Moffatt ME, Rench MA, Sahni LC, Selvarangan R, Staat MA, Szilagyi PG, Weinberg GA, Wikswo ME, Parashar UD, Payne DC. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 Sep 1; 214(5):732-8. PMID: 27302190.
      View in: PubMed
    4. Ward ML, Mijatovic-Rustempasic S, Roy S, Rungsrisuriyachai K, Boom JA, Sahni LC, Baker CJ, Rench MA, Wikswo ME, Payne DC, Parashar UD, Bowen MD. Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 May 26. PMID: 27237948.
      View in: PubMed
    5. McDade EJ, Hewlett JL, Moonnumakal SP, Baker CJ. Evaluation of Vancomycin Dosing in Pediatric Cystic Fibrosis Patients. J Pediatr Pharmacol Ther. 2016 Mar-Apr; 21(2):155-61. PMID: 27199623; PMCID: PMC4869773.
    6. Roy S, Rungsrisuriyachai K, Esona MD, Boom JA, Sahni LC, Rench MA, Baker CJ, Wikswo ME, Payne DC, Parashar UD, Bowen MD. G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis. 2015 Nov; 21(11):2103-4. PMID: 26488454.
      View in: PubMed
    7. Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, McNeal M, Klein EJ, Sahni LC, Johnston SH, Harrison CJ, Baker CJ, Bernstein DI, Moffatt ME, Tate JE, Mijatovic-Rustempasic S, Esona MD, Wikswo ME, Curns AT, Sulemana I, Bowen MD, Gentsch JR, Parashar UD. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9. PMID: 26449565.
      View in: PubMed
    8. Flores AR, Galloway-Peña J, Sahasrabhojane P, Saldaña M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, Margarit Y Ros I, Rosini R, Grandi G, Horstmann N, Teatero S, McGeer A, Fittipaldi N, Rappuoli R, Baker CJ, Shelburne SA. Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes. Proc Natl Acad Sci U S A. 2015 May 19; 112(20):6431-6. PMID: 25941374.
      View in: PubMed
    9. Edwards MS, Rench MA, Baker CJ. Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J. 2015 May; 34(5):538-9. PMID: 25545183.
      View in: PubMed
    10. Krenek LM, Eldin KW, Baker CJ. Nine-year-old girl with a left flank mass. Clin Pediatr (Phila). 2015 Jun; 54(7):703-5. PMID: 25520369.
      View in: PubMed
    11. Flores AE, Chhatwal GS, Hillier SL, Baker CJ, Ferrieri P. Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci. Curr Microbiol. 2014 Dec; 69(6):894-8. PMID: 25108378.
      View in: PubMed
    12. Oster G, Edelsberg J, Hennegan K, Lewin C, Narasimhan V, Slobod K, Edwards MS, Baker CJ. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? Vaccine. 2014 Aug 20; 32(37):4778-85. PMID: 24992717.
      View in: PubMed
    13. Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014 Jun; 133(6):e1500-7. PMID: 24843060.
      View in: PubMed
    14. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 7; 311(17):1760-9. PMID: 24794369; PMCID: PMC4333147.
    15. Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, Platt R. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis. 2014 Mar 1; 209(5):781-8. PMID: 24133184; PMCID: PMC3923540.
    16. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013 Aug 28; 31 Suppl 4:D3-6. PMID: 23973344.
      View in: PubMed
    17. Healy CM, Rench MA, Baker CJ. Reply to Leuridan et al. Clin Infect Dis. 2013 Aug; 57(3):472-3. PMID: 23580734.
      View in: PubMed
    18. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Mar 22; 62(RR-2):1-28. PMID: 23515099.
      View in: PubMed
    19. Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, Johnston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, McNeal M, Chappell J, Weinberg GA, Tasslimi A, Tate JE, Wikswo M, Curns AT, Sulemana I, Mijatovic-Rustempasic S, Esona MD, Bowen MD, Gentsch JR, Parashar UD. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20. PMID: 23487388; PMCID: PMC4618548.
    20. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis. 2013 Feb; 56(4):539-44. PMID: 23097585.
      View in: PubMed
    21. Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9. PMID: 22872730; PMCID: PMC4618559.
    22. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012 Jul; 130(1):e8-15. PMID: 22689869.
      View in: PubMed
    23. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012 Jun 13; 30(28):4123-6. PMID: 22537994; PMCID: PMC3392193.
    24. Healy CM, Baker CJ. Infant pertussis: what to do next? Clin Infect Dis. 2012 Feb 1; 54(3):328-30. PMID: 22156848.
      View in: PubMed
    25. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012 Jan 1; 54(1):78-84. PMID: 22075790.
      View in: PubMed
    26. Baker CJ. Help make your school a flu-free zone. NASN Sch Nurse. 2011 Nov; 26(6):364-7. PMID: 22165485.
      View in: PubMed
    27. Campbell JR, Hulten K, Baker CJ. Cluster of Bacillus species bacteremia cases in neonates during a hospital construction project. Infect Control Hosp Epidemiol. 2011 Oct; 32(10):1035-8. PMID: 21931256.
      View in: PubMed
    28. Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics. 2011 Sep; 128(3):611-6. PMID: 21807694.
      View in: PubMed
    29. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011 Jan 15; 52(2):157-62. PMID: 21288837.
      View in: PubMed
    30. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010 Dec; 29(12):1133-5. PMID: 20634776.
      View in: PubMed
    31. Levent F, Baker CJ, Rench MA, Edwards MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J. 2010 Nov; 29(11):1009-12. PMID: 20555292.
      View in: PubMed
    32. Patel M, Rench MA, Boom JA, Tate JE, Sahni LC, Hull JA, Gentsch JR, Parashar UD, Baker CJ. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9. PMID: 20526226.
      View in: PubMed
    33. Sahni LC, Boom JA, Patel MM, Baker CJ, Rench MA, Parashar UD, Tate JE. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine. 2010 Aug 31; 28(38):6314-7. PMID: 20637764.
      View in: PubMed
    34. Lantos PM, Charini WA, Medoff G, Moro MH, Mushatt DM, Parsonnet J, Sanders JW, Baker CJ. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jul 1; 51(1):1-5. PMID: 20504239.
      View in: PubMed
    35. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207. PMID: 20083525.
      View in: PubMed
    36. Bobo N, Baker CJ. Practice what we teach. The case for influenza vaccination among school nurses. NASN Sch Nurse. 2009 Nov; 24(6):243-5. PMID: 20440938.
      View in: PubMed
    37. Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 15; 49(6):817-40. PMID: 19659433.
      View in: PubMed
    38. Healy CM, Rench MA, Castagnini LA, Baker CJ. Pertussis immunization in a high-risk postpartum population. Vaccine. 2009 Sep 18; 27(41):5599-602. PMID: 19647062.
      View in: PubMed
    39. Pannaraj PS, Edwards MS, Ewing KT, Lewis AL, Rench MA, Baker CJ. Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine. 2009 Jul 16; 27(33):4452-6. PMID: 19490960; PMCID: PMC2778198.
    40. Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, Rosini R, Runci Y, Mora M, Buccato S, Pagani M, Tresoldi E, Berardi A, Creti R, Baker CJ, Telford JL, Grandi G. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009 Jan 1; 199(1):108-15. PMID: 19086816.
      View in: PubMed
    41. Healy CM, Baker CJ. Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J. 2009 Jan; 28(1):49-52. PMID: 19106754.
      View in: PubMed
    42. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics. 2008 Apr; 121(4):703-10. PMID: 18381534.
      View in: PubMed
    43. Bartlett AH, Rivera AL, Krishnamurthy R, Baker CJ. Thoracic actinomycosis in children: case report and review of the literature. Pediatr Infect Dis J. 2008 Feb; 27(2):165-9. PMID: 18174864.
      View in: PubMed
    44. Pannaraj PS, Kelly JK, Rench MA, Madoff LC, Edwards MS, Baker CJ. Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine. 2008 Jan 24; 26(4):502-8. PMID: 18155812; PMCID: PMC2581930.
    45. Healy CM, Baker CJ. Maternal immunization. Pediatr Infect Dis J. 2007 Oct; 26(10):945-8. PMID: 17901801.
      View in: PubMed
    46. Baker CJ, Schaffner W, Zimmerman RK. Importance of influenza vaccination for children. Am Fam Physician. 2007 Aug 1; 76(3):343-4; author reply 344, 347. PMID: 17708132.
      View in: PubMed
    47. Pannaraj PS, Kelly JK, Madoff LC, Rench MA, Lachenauer CS, Edwards MS, Baker CJ. Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis. 2007 Feb 1; 195(3):353-6. PMID: 17205473.
      View in: PubMed
    48. Baker CJ, Rench MA, Paoletti LC, Edwards MS. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007 Jan 2; 25(1):55-63. PMID: 16919857.
      View in: PubMed
    49. Manning SD, Ki M, Marrs CF, Kugeler KJ, Borchardt SM, Baker CJ, Foxman B. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis. 2006; 6:116. PMID: 16846499; PMCID: PMC1559624.
    50. Bartlett AH, Dishop MK, Baker CJ. An unusual cause of appendicitis in a child. Semin Pediatr Infect Dis. 2006 Jul; 17(3):111-2, 177-9. PMID: 16934704.
      View in: PubMed
    51. Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis. 2006 Jun; 19(3):271-6. PMID: 16645489.
      View in: PubMed
    52. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006 May 15; 42(10):1439-42. PMID: 16619157.
      View in: PubMed
    53. Pannaraj PS, Walsh TJ, Baker CJ. Advances in antifungal therapy. Pediatr Infect Dis J. 2005 Oct; 24(10):921-2. PMID: 16220093.
      View in: PubMed
    54. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis. 2005 Sep 15; 41(6):839-47. PMID: 16107984.
      View in: PubMed
    55. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005 Aug; 147(2):166-71. PMID: 16126043.
      View in: PubMed
    56. Amundson NR, Flores AE, Hillier SL, Baker CJ, Ferrieri P. DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol. 2005 Feb; 43(2):572-6. PMID: 15695647; PMCID: PMC548113.
    57. Healy CM, Baker CJ. The future of meningococcal vaccines. Pediatr Infect Dis J. 2005 Feb; 24(2):175-6. PMID: 15702048.
      View in: PubMed
    58. Edwards MS, Rench MA, Palazzi DL, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis. 2005 Feb 1; 40(3):352-7. PMID: 15668856.
      View in: PubMed
    59. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004 Nov 15; 39(10):1460-6. PMID: 15546082.
      View in: PubMed
    60. Edwards MS, Munoz FM, Baker CJ. Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J. 2004 Oct; 23(10):961-3. PMID: 15602200.
      View in: PubMed
    61. Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ. Features of invasive staphylococcal disease in neonates. Pediatrics. 2004 Oct; 114(4):953-61. PMID: 15466090.
      View in: PubMed
    62. Manning SD, Neighbors K, Tallman PA, Gillespie B, Marrs CF, Borchardt SM, Baker CJ, Pearlman MD, Foxman B. Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis. 2004 Aug 1; 39(3):380-8. PMID: 15307006.
      View in: PubMed
    63. Palazzi DL, Rench MA, Edwards MS, Baker CJ. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis. 2004 Aug 1; 190(3):558-64. PMID: 15243932.
      View in: PubMed
    64. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004 Jul 15; 190(2):335-40. PMID: 15216470.
      View in: PubMed
    65. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Edwards MS, Kasper DL. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12. PMID: 14999615.
      View in: PubMed
    66. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis. 2004 Mar 15; 189(6):1097-102. PMID: 14999614.
      View in: PubMed
    67. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol. 2004 Jan; 42(1):146-50. PMID: 14715745; PMCID: PMC321726.
    68. Amaya RA, Baker CJ, Keitel WA, Edwards MS. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc. 2004 Jan; 52(1):46-50. PMID: 14687314.
      View in: PubMed
    69. Englund JA, Raskino C, Vavro C, Palumbo P, Ross LL, McKinney R, Nikolic-Djokic D, Colgrove RC, Baker CJ. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. Pediatr Infect Dis J. 2004 Jan; 23(1):15-22. PMID: 14743040.
      View in: PubMed
    70. Chantry CJ, Byrd RS, Englund JA, Baker CJ, McKinney RE. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J. 2003 Dec; 22(12):1033-9. PMID: 14688560.
      View in: PubMed
    71. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003 Jul 28; 21(24):3468-72. PMID: 12850362.
      View in: PubMed
    72. Kanto WP, Baker CJ. New recommendations for prevention of early-onset group B streptococcal disease in newborns. Pediatr Rev. 2003 Jul; 24(7):219-21. PMID: 12837958.
      View in: PubMed
    73. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 1; 188(1):66-73. PMID: 12825173.
      View in: PubMed
    74. Capparelli EV, Englund JA, Connor JD, Spector SA, McKinney RE, Palumbo P, Baker CJ. Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. J Clin Pharmacol. 2003 Feb; 43(2):133-40. PMID: 12616665.
      View in: PubMed
    75. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol. 2003 Jan; 101(1):74-9. PMID: 12517649.
      View in: PubMed
    76. Manning SD, Tallman P, Baker CJ, Gillespie B, Marrs CF, Foxman B. Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology. 2002 Sep; 13(5):533-9. PMID: 12192222.
      View in: PubMed
    77. Benson JA, Flores AE, Baker CJ, Hillier SL, Ferrieri P. Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol. 2002 Jun; 292(1):37-42. PMID: 12139427.
      View in: PubMed
    78. Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis. 2002 May 1; 185(9):1277-84. PMID: 12001045.
      View in: PubMed
    79. Amaya RA, Baker CJ. Bilateral lung abscesses in an adolescent. Semin Pediatr Infect Dis. 2002 Apr; 13(2):71, 142. PMID: 12122954.
      View in: PubMed
    80. Guttormsen HK, Baker CJ, Nahm MH, Paoletti LC, Zughaier SM, Edwards MS, Kasper DL. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun. 2002 Apr; 70(4):1724-38. PMID: 11895934; PMCID: PMC127872.
    81. Lachenauer CS, Baker CJ, Baron MJ, Kasper DL, Gravekamp C, Madoff LC. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis. 2002 Feb 1; 185(3):368-74. PMID: 11807719.
      View in: PubMed
    82. Bliss SJ, Manning SD, Tallman P, Baker CJ, Pearlman MD, Marrs CF, Foxman B. Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis. 2002 Jan 15; 34(2):184-90. PMID: 11740706.
      View in: PubMed
    BAKER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _